“Repurposing FDA-Approved Antimalarial Drugs: Mefloquine As a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy”. Indian Journal of Chemistry (IJC) 64, no. 7 (July 24, 2025): 730–745. Accessed May 14, 2026. https://or.niscpr.res.in/index.php/IJC/article/view/16642.